Neural Regeneration Research ›› 2024, Vol. 19 ›› Issue (2): 296-301.doi: 10.4103/1673-5374.374655

Previous Articles     Next Articles

The dorsal root ganglion as a target for neurorestoration in neuropathic pain

Guillermo Estivill-Torrús1, 2, Ana Belen Martínez-Padilla3, Lourdes Sánchez-Salido1, 2, Anne Baron-Van Evercooren4, Beatriz García-Díaz1, 2, *#br#   

  1. 1Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), Málaga, Spain; 2Unidad Clínica de Neurociencias, Hospital Regional Universitario de Málaga, Málaga, Spain; 3Departamento de Biología Molecular y Bioquímica, Universidad de Málaga, Spain; 4Sorbonne Université, Institut du Cerveau - Paris Brain Institute-ICM, INSERM, CNRS, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
  • Online:2024-02-15 Published:2023-08-29
  • Contact: Beatriz García-Díaz, PhD, beatriz.garcia@ibima.eu.
  • Supported by:
    This work was financially supported by several sources that deserve to be mentioned. GET is under a contract of the “Nicolás Monardes” program (RC-0002-2021) from the Andalusian Health Service, Andalusian Regional Ministry of Health and Consumption and has received funds from the Excellent Project from Andalusian Government (ProyExcel_00996). ABV was funded by the French Multiple Sclerosis Foundation (ARSEP, 1259 & 1254), the National Multiple Sclerosis Society (NMSS; RG 5088-A-1), and the program ‘’Investissements d’Avenir’’ (ANR-10-IAIHU-06 and ANR-11-INBS-0011–NeurATRIS). BGD is under a “Miguel Servet” contract (CP20-0049) from the Health Institute Carlos III, Ministry of Science and Innovation, Spain, and has received grants from Andalusian Government and the European Commission under the Seventh Framework Program of the European Union (agreement Num. 291730, contract TAHUB- II-107), ARSEP 1254, IBRO Return Home Fellowship, AES2022 from Health Institute Carlos III (PI22/01141) and the Excellent Project from Andalusian Regional Ministry of University, Research and Innovation (ProyExcel_00996).

Abstract: Neuropathic pain is a severe and chronic condition widely found in the general population. The reason for this is the extensive variety of damage or diseases that can spark this unpleasant constant feeling in patients. During the processing of pain, the dorsal root ganglia constitute an important region where dorsal root ganglion neurons play a crucial role in the transmission and propagation of sensory electrical stimulation. Furthermore, the dorsal root ganglia have recently exhibited a regenerative capacity that should not be neglected in the understanding of the development and resolution of neuropathic pain and in the elucidation of innovative therapies. Here, we will review the complex interplay between cells (satellite glial cells and inflammatory cells) and factors (cytokines, neurotrophic factors and genetic factors) that takes place within the dorsal root ganglia and accounts for the generation of the aberrant excitation of primary sensory neurons occurring in neuropathic pain. More importantly, we will summarize an updated view of the current pharmacologic and nonpharmacologic therapies targeting the dorsal root ganglia for the treatment of neuropathic pain.

Key words: cytokines, dorsal root ganglia, genetic factors, neuropathic pain, neurotrophic factors, pharmacologic and nonpharmacologic therapies, satellite glial cells, sensory neurons